Outcome of the 11th CoC Meeting held on 26-06-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech, currently under the Corporate Insolvency Resolution Process (CIRP), held its 11th CoC meeting on June 26, 2025. The company is in insolvency following an NCLT Hyderabad order dated January 17, 2025 in C.P.(IB) 277/7/HDB/2023. The only agenda item — approving the appointment of CA Asmita Gupta to handle Income Tax appeals for AY 2013-14 and AY 2014-15 at a consolidated fee of Rs. 75,000 (plus actual expenses) — was approved by 99.12% of CoC members. The cost will be treated as part of the insolvency resolution process cost. The Resolution Professional Namrata Randeri was authorized to disburse these funds.
This is a routine procedural update during ongoing insolvency. The company remains under CIRP with no resolution plan yet approved; shareholders face significant uncertainty as equity typically gets heavily diluted or written off in IBC proceedings. No immediate positive or negative stock catalyst from this particular filing.